High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The study is designed to test the hypothesis that high dose candesartan treatment compared to
quinapril is able to reduce intima hyperproliferation and the restenosis rate after stent
angioplasty in peripheral occlusive artery disease.